[New drugs for the treatment of obesity].
Mustajoki
P
P
D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D001067:Appetite Depressants / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003503:Cyclobutanes / Q000627:therapeutic use*; D004032:Diet; D006801:Humans; D007783:Lactones / Q000627:therapeutic use*; D009765:Obesity / Q000188:drug therapy* / Q000453:epidemiology; D000077403:Orlistat; D013997:Time Factors; D016896:Treatment Outcome; D015431:Weight Loss / Q000187:drug effects
D019440:Anti-Obesity Agents; D001067:Appetite Depressants; D003503:Cyclobutanes; D007783:Lactones; D000077403:Orlistat; C058254:sibutramine